SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 77.42 |
Enterprise Value ($M) | 56.39 |
Book Value ($M) | 15.89 |
Book Value / Share | 0.23 |
Price / Book | 4.87 |
NCAV ($M) | 13.42 |
NCAV / Share | 0.19 |
Price / NCAV | 5.77 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.94 |
Return on Assets (ROA) | -3.99 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.26 |
Current Ratio | 2.26 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 24.04 |
Assets | 26.50 |
Liabilities | 10.61 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Highbridge Capital Management Llc | 9.90 | 537.71 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
462,594 | 1,296,463 | 35.68 | |
644,556 | 1,583,512 | 40.70 | |
825,717 | 2,306,744 | 35.80 | |
503,952 | 1,549,905 | 32.52 | |
416,913 | 1,505,901 | 27.69 | |
(click for more detail) |
Similar Companies | |
---|---|
SILO – Silo Pharma, Inc. | SLGL – Sol-Gel Technologies Ltd. |
SLRX – Salarius Pharmaceuticals, Inc. | SNDL – SNDL Inc. |
SNGX – Soligenix, Inc. |
Financial data and stock pages provided by
Fintel.io